Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ark Health vs Onyx Weight Loss

Ark Health
Graded #406

Lower grade

vs+2
Onyx Weight Loss
Graded #359

Higher grade

The verdict

Onyx Weight Loss takes it — 58.8/100 to 56.8/100, but only just.

Onyx Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Onyx Weight Loss is a nurse-practitioner-led telehealth clinic based in Mooresville, NC, offering GLP-1 and GLP-1/GIP weight-loss medications alongside peptides and HRT across 8 states. Ark Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOnyx Weight Loss +9
34
43
Dose & formulationArk Health +24
88
64
Clinical oversightOnyx Weight Loss +16
59
75
Labs & monitoringOnyx Weight Loss +11
52
63
FulfillmentArk Health +3
56
53
Contract termsEven
55
55
Ark Health · left barOnyx Weight Loss · right bar

The numbers

MetricArk HealthOnyx Weight Loss
WeighScore56.8/10058.8/100
GradeCC
Scorecard rank#406#359
Semaglutide$1,399/mo (brand Ozempic)$228/mo (starting dose, compounded)
Tirzepatide$1,499/mo (brand Mounjaro)$280/mo (starting dose, compounded)
CoverageCoverage not published8 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Ark Health

Graded #406 · C

Strengths

  • Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
  • Consistent pricing at all dosages — flat rate, no escalation as you titrate up
  • Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
  • Free expedited shipping included
  • Phone support published (uncommon among DTC platforms)

Where it loses points

  • States served not listed — can't confirm coverage in your state without contacting support
  • LegitScript status not disclosed — no badge or verifiable ID
  • FDA compounded-medication disclaimer not displayed
  • Medical director / clinical lead not named — only generic 'certified healthcare providers'
  • Pharmacy partner not named; 503A vs 503B unspecified
Onyx Weight Loss

Graded #359 · C

Strengths

  • Competitive entry pricing: semaglutide from $228/mo and tirzepatide from $280/mo with medication + supplies included
  • Nurse-practitioner-led care: founder Tasha Vangile FNP-C (20+ years) and Stephanie Robison APRN-CNP (27 years experience)
  • Low-cost $99/mo GLP-1 microdosing option for patients who prefer a gradual titration start
  • Strive Pharmacy partnership implies compounded 503A-quality supply chain from a known pharmacy
  • Multi-modal clinic: GLP-1 + peptides + HRT + nutrition coaching available under one provider team

Where it loses points

  • Only 8 states (NC, CO, ME, VT, VA, IA, NH, PA) — excludes the majority of the US
  • No LegitScript certification; credentialing evidence limited to local 2025 Best of Iredell award
  • Specific drug names (semaglutide/tirzepatide) never stated on website; compounded status inferred, not disclosed
  • Labs not included or mentioned; no baseline bloodwork protocol published
  • Pricing shown as 'Starting at' with no dose-escalation tier pricing disclosed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard